The North America bacterial vaginosis drug market is witnessing notable expansion due to growing awareness of women’s health and increasing prevalence of vaginal infections. According to industry insights, the North America Bacterial Vaginosis Drug Market size is expected to reach US$ 1,688.3 million by 2031 from US$ 942.6 million in 2024, registering a strong CAGR of 8.5% from 2023 to...